• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇-法尼基硫代水杨酸端接树枝状聚合物胶束作为紫杉醇靶向递送的改良制剂

PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.

作者信息

Zhang Xiaolan, Huang Yixian, Zhao Wenchen, Chen Yichao, Zhang Peng, Li Jiang, Venkataramanan Raman, Li Song

机构信息

Center for Pharmacogenetics, ‡Department of Pharmaceutical Sciences, School of Pharmacy, and §University of Pittsburgh Cancer Institute, University of Pittsburgh , Pittsburgh, Pennsylvania 15261, United States.

出版信息

Mol Pharm. 2014 Aug 4;11(8):2807-14. doi: 10.1021/mp500181x. Epub 2014 Jul 11.

DOI:10.1021/mp500181x
PMID:24987803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4123940/
Abstract

We have recently designed and developed a dual-functional drug carrier that is based on poly(ethylene glycol) (PEG)-derivatized farnesylthiosalicylate (FTS, a nontoxic Ras antagonist). PEG5K-FTS2 readily form micelles (20-30 nm) and hydrophobic drugs such as paclitaxel (PTX) could be effectively loaded into these micelles. PTX formulated in PEG5K-FTS2 micelles showed an antitumor activity that was more efficacious than Taxol in a syngeneic mouse model of breast cancer (4T1.2). In order to further improve our PEG-FTS micellar system, four PEG-FTS conjugates were developed that vary in the molecular weight of PEG (PEG2K vs PEG5K) and the molar ratio of PEG/FTS (1/2 vs 1/4) in the conjugates. These conjugates were characterized including CMC, drug loading capacity, stability, and their efficacy in delivery of anticancer drug PTX to tumor cells in vitro and in vivo. Our data showed that the conjugates with four FTS molecules were more effective than the conjugates with two molecules of FTS and that FTS conjugates with PEG5K were more effective than the counterparts with PEG2K in forming stable mixed micelles. PTX formulated in PEG5K-FTS4 micelles was the most effective formulation in inhibiting the tumor growth in vivo.

摘要

我们最近设计并开发了一种基于聚乙二醇(PEG)衍生的法尼基硫代水杨酸酯(FTS,一种无毒的Ras拮抗剂)的双功能药物载体。PEG5K-FTS2很容易形成胶束(20 - 30纳米),疏水性药物如紫杉醇(PTX)可以有效地负载到这些胶束中。在同基因乳腺癌小鼠模型(4T1.2)中,用PEG5K-FTS2胶束配制的PTX显示出比紫杉醇更有效的抗肿瘤活性。为了进一步改进我们的PEG-FTS胶束系统,我们开发了四种PEG-FTS缀合物,它们在PEG的分子量(PEG2K与PEG5K)以及缀合物中PEG/FTS的摩尔比(1/2与1/4)方面有所不同。对这些缀合物进行了表征,包括临界胶束浓度、载药能力、稳定性以及它们在体外和体内将抗癌药物PTX递送至肿瘤细胞的功效。我们的数据表明,含有四个FTS分子的缀合物比含有两个FTS分子的缀合物更有效,并且含有PEG5K的FTS缀合物在形成稳定的混合胶束方面比含有PEG2K的对应物更有效。用PEG5K-FTS4胶束配制的PTX是体内抑制肿瘤生长最有效的制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/07bfd038291d/mp-2014-00181x_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/726b8ee0cd44/mp-2014-00181x_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/16d3c3ce6b70/mp-2014-00181x_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/ab647534e757/mp-2014-00181x_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/372c53b3e5a6/mp-2014-00181x_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/8959d5fe722e/mp-2014-00181x_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/cebf68cafd28/mp-2014-00181x_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/9db3fecf80bf/mp-2014-00181x_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/07bfd038291d/mp-2014-00181x_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/726b8ee0cd44/mp-2014-00181x_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/16d3c3ce6b70/mp-2014-00181x_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/ab647534e757/mp-2014-00181x_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/372c53b3e5a6/mp-2014-00181x_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/8959d5fe722e/mp-2014-00181x_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/cebf68cafd28/mp-2014-00181x_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/9db3fecf80bf/mp-2014-00181x_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e9/4123940/07bfd038291d/mp-2014-00181x_0010.jpg

相似文献

1
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.聚乙二醇-法尼基硫代水杨酸端接树枝状聚合物胶束作为紫杉醇靶向递送的改良制剂
Mol Pharm. 2014 Aug 4;11(8):2807-14. doi: 10.1021/mp500181x. Epub 2014 Jul 11.
2
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.PEG-香叶基硫代水杨酸盐缀合物作为紫杉醇的纳米胶束载体。
Bioconjug Chem. 2013 Mar 20;24(3):464-72. doi: 10.1021/bc300608h. Epub 2013 Mar 1.
3
Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.用于改善紫杉醇递送的还原敏感型双功能纳米胶束
Bioconjug Chem. 2014 Sep 17;25(9):1689-96. doi: 10.1021/bc500292j. Epub 2014 Aug 14.
4
Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.用于增强紫杉醇递送的改良胶束制剂
Mol Pharm. 2017 Jan 3;14(1):31-41. doi: 10.1021/acs.molpharmaceut.6b00581. Epub 2016 Nov 30.
5
A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.一种由具有法尼基硫代水杨酸侧基的聚合物组装而成的前药胶束载体,用于改善紫杉醇的递送。
Acta Biomater. 2016 Oct 1;43:282-291. doi: 10.1016/j.actbio.2016.07.014. Epub 2016 Jul 12.
6
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.聚乙二醇化维生素 E 的设计与表征及其作为紫杉醇纳米胶束制剂的递送载体
Mol Pharm. 2013 Aug 5;10(8):2880-90. doi: 10.1021/mp300729y. Epub 2013 Jul 11.
7
Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.用于紫杉醇肿瘤靶向递送的芴甲氧羰基共轭聚乙二醇 - 维生素E2胶束:增强药物 - 载体相互作用和载药量
AAPS J. 2014 Nov;16(6):1282-91. doi: 10.1208/s12248-014-9651-2. Epub 2014 Sep 6.
8
A multi-functional polymeric carrier for simultaneous positron emission tomography imaging and combination therapy.一种多功能聚合物载体,用于正电子发射断层成像和联合治疗。
Acta Biomater. 2018 Jul 15;75:312-322. doi: 10.1016/j.actbio.2018.06.010. Epub 2018 Jun 6.
9
Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif.通过具有界面药物相互作用基序的双功能纳米载体实现抗癌药物的靶向递送。
Biomacromolecules. 2014 Nov 10;15(11):4326-35. doi: 10.1021/bm501339j. Epub 2014 Oct 28.
10
PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.聚乙二醇衍生化二十八烷醇作为紫杉醇递送的胶束载体。
Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030. Epub 2016 Jan 18.

引用本文的文献

1
Application of Nanomicelles in Enhancing Bioavailability and Biological Efficacy of Bioactive Nutrients.纳米胶束在提高生物活性营养素的生物利用度和生物学功效方面的应用。
Polymers (Basel). 2022 Aug 11;14(16):3278. doi: 10.3390/polym14163278.
2
Surface-modified nanotherapeutics targeting atherosclerosis.针对动脉粥样硬化的表面修饰纳米治疗药物。
Biomater Sci. 2022 Sep 27;10(19):5459-5471. doi: 10.1039/d2bm00660j.
3
Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination.用于改进肿瘤疫苗接种的法尼基硫代水杨酸衍生化的基于聚乙烯亚胺的纳米复合物

本文引用的文献

1
Nanomicellar carriers for targeted delivery of anticancer agents.用于靶向递送抗癌药物的纳米胶束载体。
Ther Deliv. 2014 Jan;5(1):53-68. doi: 10.4155/tde.13.135.
2
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.聚乙二醇化维生素 E 的设计与表征及其作为紫杉醇纳米胶束制剂的递送载体
Mol Pharm. 2013 Aug 5;10(8):2880-90. doi: 10.1021/mp300729y. Epub 2013 Jul 11.
3
Immunomodulatory properties of farnesoids: the new steroids?法呢甾醇类的免疫调节特性:新型甾体?
Mol Ther Nucleic Acids. 2021 Sep 20;26:594-602. doi: 10.1016/j.omtn.2021.09.006. eCollection 2021 Dec 3.
4
Telodendrimers: Promising Architectural Polymers for Drug Delivery.树状聚合物:用于药物传递的有前途的结构聚合物。
Molecules. 2020 Sep 2;25(17):3995. doi: 10.3390/molecules25173995.
5
Telodendrimer-Based Macromolecular Drug Design using 1,3-Dipolar Cycloaddition for Applications in Biology.基于树状大分子的 1,3-偶极环加成在生物医学中的应用的大分子药物设计
Molecules. 2020 Feb 15;25(4):857. doi: 10.3390/molecules25040857.
6
PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy.用于改善癌症治疗的聚乙二醇衍生化双功能纳米胶束
Front Pharmacol. 2019 Jul 19;10:808. doi: 10.3389/fphar.2019.00808. eCollection 2019.
7
A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin.一种基于布洛芬共轭聚合物的纳米胶束前药载体,用于共递送阿霉素。
Front Pharmacol. 2018 Aug 14;9:781. doi: 10.3389/fphar.2018.00781. eCollection 2018.
8
Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems.后聚合修饰中的组合方法在治疗性递药系统的合理开发中的应用。
Acta Biomater. 2018 Jun;73:21-37. doi: 10.1016/j.actbio.2018.04.010. Epub 2018 Apr 12.
9
Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo.锝-99m标记的紫杉醇作为乳腺癌体内成像探针。
Biomed Pharmacother. 2017 May;89:146-151. doi: 10.1016/j.biopha.2017.02.003. Epub 2017 Mar 24.
10
A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.一种由具有法尼基硫代水杨酸侧基的聚合物组装而成的前药胶束载体,用于改善紫杉醇的递送。
Acta Biomater. 2016 Oct 1;43:282-291. doi: 10.1016/j.actbio.2016.07.014. Epub 2016 Jul 12.
Curr Med Chem. 2013;20(10):1218-24. doi: 10.2174/0929867311320100002.
4
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.PEG-香叶基硫代水杨酸盐缀合物作为紫杉醇的纳米胶束载体。
Bioconjug Chem. 2013 Mar 20;24(3):464-72. doi: 10.1021/bc300608h. Epub 2013 Mar 1.
5
Nanotechnology: Carrying drugs.纳米技术:运载药物。
Nature. 2012 Nov 22;491(7425):S58-60. doi: 10.1038/491s58a.
6
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.PEG 修饰的密执安瑞香素作为载紫杉醇的胶束给药系统用于治疗乳腺癌和前列腺癌
Biomaterials. 2013 Feb;34(5):1591-600. doi: 10.1016/j.biomaterials.2012.10.073. Epub 2012 Nov 23.
7
Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.赖氨酸连接的生育酚聚乙二醇 2000 琥珀酸二酯星形嵌段共聚物用于阿霉素递送,逆转多药耐药性。
Biomaterials. 2012 Oct;33(28):6877-88. doi: 10.1016/j.biomaterials.2012.06.019. Epub 2012 Jul 6.
8
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.聚乙二醇化赝樱素作为紫杉醇的双重功能载体。
Bioconjug Chem. 2012 Jul 18;23(7):1443-51. doi: 10.1021/bc3000468. Epub 2012 Jun 20.
9
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.小于 100nm 的聚合物胶束在通透性差的肿瘤中的积累取决于粒径大小。
Nat Nanotechnol. 2011 Oct 23;6(12):815-23. doi: 10.1038/nnano.2011.166.
10
Inhibition of Ras for cancer treatment: the search continues.抑制 Ras 用于癌症治疗:探索仍在继续。
Future Med Chem. 2011 Oct;3(14):1787-808. doi: 10.4155/fmc.11.121.